Oxidative stress, telomere damage and Werner syndrome.

氧化应激、端粒损伤和维尔纳综合征。

基本信息

项目摘要

DESCRIPTION (provided by applicant): As population demographics in the US continue to skew towards older ages, determining the processes that underlie the physical deterioration that occurs in normal aging becomes of increasing importance. An analysis of the genetics of human aging is possible and promises to yield new insight into these processes. The genes responsible for most genetic disorders of human premature aging have been identified. Werner's syndrome (WS) is one such disorder. The overall aim of this proposal is to use the molecular analysis of WS to better understand the aging process in the normal human population. WS is a human genetic disorder with features suggestive of accelerated aging. The gene defective in most cases of WS encodes a polypeptide with both helicase and exonuclease activities. Multiple studies support a role or roles of the WS protein in telomere maintenance. Telomere loss is predicted to reflect the sum of DNA lost uniformly at all telomeres during replication, and sporadic loss events occurring at individual telomeres with variable frequency. The latter class of events includes loss of telomere sequences due to damage to telomere DNA. Using a simple inhibition of colony formation assay, we have found that primary WS fibroblasts are defective in repair of oxidative telomere damage. Based on our preliminary data and published analyses of the effect of oxidative stress on telomere sequence loss in normal fibroblasts and studies of the role of WS protein in telomere processing, we suggest a model in which the WS protein participates in repair of damage to telomeres. In Aim 1, we will study the nature of the lesions produced by oxidative damage at telomeres and the mechanisms by which the cell recognizes and responds to this damage. In Aim 2, we will study the role of the WS protein in the response to telomere damage caused by oxidative stress. The mechanism by which telomerase suppresses the sensitivity of WS fibroblasts to oxidative stress will be determined in Aim 3. The studies in Aims 1-3 will be performed in tissue culture; to determine the in vivo relevance of the role of oxidative stress in the development of phenotypes related to telomere deficiency, in Aim 4 we will study mice that are deficient in combinations of the WS helicase, telomerase RNA component, and superoxide dismutase 2. These studies provide a novel link between oxidative stress, telomere dysfunction and a human progeroid syndrome. The relative contribution of sporadic loss events and end-replication inefficiency to rates of overall telomere sequence loss is currently unknown. Increased understanding of sporadic loss events and the pathways influencing their occurrence is of critical importance in devising strategies to minimize telomere loss.
描述(由申请人提供):随着美国人口统计数据继续向老年化倾斜,确定在正常衰老过程中发生的身体退化的过程变得越来越重要。对人类衰老的遗传学分析是可能的,并有望对这些过程产生新的见解。导致人类早衰的大多数遗传疾病的基因已经被确定。沃纳氏综合征(WS)就是这样一种疾病。本提案的总体目标是利用WS的分子分析来更好地了解正常人群的衰老过程。WS是一种人类遗传疾病,具有加速衰老的特征。在大多数WS病例中,有缺陷的基因编码一种具有解旋酶和外切酶活性的多肽。多项研究支持WS蛋白在端粒维持中的一个或多个作用。预计端粒丢失反映了复制过程中所有端粒DNA均匀丢失的总和,以及个别端粒以不同频率发生的零星丢失事件。后一类事件包括端粒DNA损伤引起的端粒序列丢失。通过简单的集落形成抑制实验,我们发现原代WS成纤维细胞在氧化端粒损伤的修复中存在缺陷。基于我们对氧化应激对正常成纤维细胞端粒序列丢失影响的初步数据和已发表的分析,以及对WS蛋白在端粒加工中的作用的研究,我们提出了一个WS蛋白参与端粒损伤修复的模型。在目标1中,我们将研究端粒氧化损伤产生的病变的性质以及细胞识别和响应这种损伤的机制。在Aim 2中,我们将研究WS蛋白在氧化应激引起的端粒损伤反应中的作用。端粒酶抑制WS成纤维细胞对氧化应激敏感性的机制将在Aim 3中确定。Aims 1-3中的研究将在组织培养中进行;为了确定氧化应激在端粒缺乏相关表型发展中的体内相关性,在Aim 4中,我们将研究WS解旋酶、端粒酶RNA组分和超氧化物歧化酶2组合缺乏的小鼠。这些研究提供了氧化应激、端粒功能障碍和人类类早衰综合征之间的新联系。零星丢失事件和末端复制效率低下对整体端粒序列丢失率的相对贡献目前尚不清楚。增加对零星损失事件和影响其发生的途径的理解对于设计最小化端粒损失的策略至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT Anthony MARCINIAK其他文献

ROBERT Anthony MARCINIAK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT Anthony MARCINIAK', 18)}}的其他基金

Oxidative stress, telomere damage and Werner syndrome.
氧化应激、端粒损伤和沃纳综合征。
  • 批准号:
    8046397
  • 财政年份:
    2007
  • 资助金额:
    $ 29.93万
  • 项目类别:
Oxidative stress, telomere damage and Werner syndrome.
氧化应激、端粒损伤和维尔纳综合征。
  • 批准号:
    7586091
  • 财政年份:
    2007
  • 资助金额:
    $ 29.93万
  • 项目类别:
Oxidative stress, telomere damage and Werner syndrome.
氧化应激、端粒损伤和沃纳综合征。
  • 批准号:
    7405360
  • 财政年份:
    2007
  • 资助金额:
    $ 29.93万
  • 项目类别:
Oxidative stress, telomere damage and Werner syndrome.
氧化应激、端粒损伤和沃纳综合征。
  • 批准号:
    7795121
  • 财政年份:
    2007
  • 资助金额:
    $ 29.93万
  • 项目类别:
Oxidative stress and telomere maintenance in vivo
体内氧化应激和端粒维持
  • 批准号:
    6547872
  • 财政年份:
    2002
  • 资助金额:
    $ 29.93万
  • 项目类别:
MOLECULAR ANALYSIS OF THE WERNERS GENE PRODUCT
维尔纳基因产物的分子分析
  • 批准号:
    6055335
  • 财政年份:
    1997
  • 资助金额:
    $ 29.93万
  • 项目类别:
MOLECULAR ANALYSIS OF THE WERNERS GENE PRODUCT
维尔纳基因产物的分子分析
  • 批准号:
    2384365
  • 财政年份:
    1997
  • 资助金额:
    $ 29.93万
  • 项目类别:
MOLECULAR ANALYSIS OF THE WERNERS GENE PRODUCT
维尔纳基因产物的分子分析
  • 批准号:
    2769278
  • 财政年份:
    1997
  • 资助金额:
    $ 29.93万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了